Apexigen, Inc. Financing Cash Flow
Apexigen, Inc. reported Financing Cash Flow of $2.18 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2023-08-10
- Apexigen, Inc. net cash provided by (used in) financing activities for the quarter ending 2023-06-30 was -$360.00K.
- Apexigen, Inc. net cash provided by (used in) financing activities for the quarter ending 2023-03-31 was $2.54M.
- Apexigen, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-12-31 was -$878.00K.
- Apexigen, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-09-30 was $12.55M.
- Apexigen, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $11.10M, a 29891.89% increase from fiscal 2021.
- Apexigen, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $37.00K.
| Period end | Net Cash Provided by (Used in) Financing Activities 1 month | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 4 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 7 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | -$360.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $2.18M 10-Q · filed 2023-08-10 | $1.30M derived: sum of 3 quarters · filed 2023-08-10 | $13.85M derived: sum of 4 quarters · filed 2023-08-10 | |||||||
| 2023-03-31 | $2.54M 10-Q · filed 2023-05-15 | $1.66M derived: sum of 2 quarters · filed 2023-05-15 | $14.21M derived: sum of 3 quarters · filed 2023-05-15 | $13.71M derived: sum of 4 quarters · filed 2023-08-10 | |||||||
| 2022-12-31 | -$878.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $11.67M derived: sum of 2 quarters · filed 2023-02-22 | $11.17M derived: sum of 3 quarters · filed 2023-08-10 | $11.10M 10-K · filed 2023-02-22 | |||||||
| 2022-09-30 | $12.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $12.05M derived: sum of 2 quarters · filed 2023-08-10 | $11.97M 10-Q · filed 2022-11-14 | $11.96M derived: sum of 4 quarters · filed 2023-08-10 | |||||||
| 2022-06-30 | -$504.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$576.00K 10-Q · filed 2023-08-10 | -$6.18M 10-Q · filed 2022-08-18 | -$588.00K derived: sum of 3 quarters · filed 2023-08-10 | -$59.28M derived: sum of 4 quarters · filed 2023-08-10 | ||||||
| 2022-03-31 | -$72.00K 10-Q · filed 2023-05-15 | $0.00 10-Q · filed 2022-05-23 | -$84.00K derived: sum of 2 quarters · filed 2023-05-15 | -$58.78M derived: sum of 3 quarters · filed 2023-05-15 | -$58.78M derived: sum of 4 quarters · filed 2023-05-15 | ||||||
| 2021-12-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$58.71M derived: sum of 2 quarters · filed 2023-02-22 | -$58.71M derived: sum of 3 quarters · filed 2023-02-22 | $37.00K 10-K · filed 2023-02-22 | $58.74M 10-K · filed 2022-04-07 | ||||||
| 2021-09-30 | -$58.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$58.69M derived: sum of 2 quarters · filed 2022-11-14 | $49.00K 10-Q · filed 2022-11-14 | $58.74M 10-Q · filed 2021-12-09 | |||||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-18 | $58.74M 10-Q · filed 2022-08-18 | |||||||||
| 2021-03-31 | $58.74M 10-Q · filed 2022-05-23 | ||||||||||
| 2020-12-31 | $978.00 10-K · filed 2022-04-07 | ||||||||||
| 2020-09-30 | $978.00 10-Q · filed 2021-12-09 | ||||||||||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 |